Knowing the Horses and Recognizing the Zebras: Clinicians’ Perspectives on End-of-Life Trajectories in Advanced Breast Cancer Using a Nominal Group Technique
Using a Nominal Group Technique with healthcare professionals, this study identifies and prioritizes both common ("horses") and rare but critical ("zebras") end-of-life trajectories in advanced breast cancer to enhance clinical recognition and improve anticipatory care.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person lives with advanced breast cancer, the journey toward the end of life is rarely a straight line. It is a path that can twist in many directions, shaped by how the disease spreads and how the body responds to treatment. For doctors and nurses, the most difficult part of their work is often knowing when the final chapter is beginning. They must decide when to shift from trying to cure the illness to focusing entirely on comfort. This decision is not just about counting days; it is about recognizing specific patterns of decline. In the past, medical training often relied on general rules that applied to all cancers, but as treatments for breast cancer have improved and patients live longer, the way the disease ends has become more complex. Clinicians now face a landscape where the usual signs of dying might look different, or where rare and sudden events can change everything in a matter of hours. Understanding these specific patterns is essential for helping patients and their families prepare for what comes next, ensuring that care matches the reality of the situation.
To map out these patterns, a team of researchers at Radboud University Medical Center in the Netherlands gathered a group of experienced doctors and nurses to share what they see in their daily practice. They did not simply ask for opinions; they used a structured method called the nominal group technique. This approach brings together experts, asks them to think silently and generate ideas on their own, and then discusses and ranks those ideas together to find the most important ones. The group consisted of eleven healthcare professionals, including general practitioners, medical oncologists, and hospice physicians, all of whom had spent at least two years caring for patients with advanced breast cancer. They met online to answer two specific questions: what are the common ways these patients decline in their final weeks, and what are the rare but critical events that doctors must be ready for?
The participants described two distinct types of end-of-life scenarios, which they vividly labeled as "horses" and "zebras." The "horses" represent the expected, common patterns that clinicians see frequently. The most prominent of these was something the group called the "final common pathway." This is a recognizable sequence where a patient stops eating and drinking, leading to a state of severe weight loss and weakness known as cachexia. As the body slows down, the patient becomes increasingly sleepy and eventually loses the ability to move. This process, which often unfolds over just a few days rather than weeks, signals that the body is shutting down. While this pattern is not unique to breast cancer, the clinicians emphasized that it is a clear and reliable sign that the end is near. They also identified another common "horse": a prolonged trajectory where a patient, often younger and physically stronger, suffers from a mix of symptoms over a long period. In these cases, the burden of the illness becomes unbearable over time, sometimes leading to requests for medical aid in dying, a legal option in the Netherlands.
In contrast to these predictable paths, the group highlighted the "zebras": rare but critical events that happen infrequently but can cause sudden, dramatic changes. These are the scenarios that doctors must keep in mind even though they do not happen often. One major category involves acute neurological problems, such as a sudden seizure or rapid decline caused by tumors pressing on the brain or spinal cord. These events can alter a patient's condition within hours, requiring immediate decisions. Another critical "zebra" is severe bleeding, which can occur if a tumor erodes into a blood vessel. The clinicians described this as a terrifying event, particularly when it happens at home, leaving families feeling powerless without warning. A third group of rare events includes sudden blockages in the lungs or digestive system, which demand quick action. The researchers found that while these events are not the norm, the potential for them to cause rapid deterioration means that clinicians must be prepared to recognize them instantly.
The study suggests that the value of knowing these patterns goes beyond simple observation. By distinguishing between the common "horses" and the rare "zebras," doctors can better guide conversations with patients and their families. They can explain what is likely to happen in the final weeks, helping everyone prepare emotionally and practically. At the same time, being aware of the rare possibilities allows clinicians to act quickly if the situation changes unexpectedly, avoiding unnecessary panic or crisis-driven interventions. The researchers noted that this framework is particularly important now, as new treatments allow patients to live longer with advanced disease, creating a more varied and complex end-of-life experience than in the past. The findings do not claim to have solved the mystery of death, but they offer a clearer, more specific map for the final journey of patients with advanced breast cancer, helping caregivers navigate the transition from active treatment to comfort with greater confidence and clarity.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.